Roche Holding AG (OTCQX International Premier:RHHVF)
| 279.75 Delayed Data As of Sep 25 |  +3.24 / +1.17%Today’s Change | 268.39 Today|||52-Week Range 349.45 | -10.19% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $191.3B |
Company Description
Roche Holding AG is a research healthcare company. It operates through the Pharmaceuticals and Diagnostics segments. The Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
Contact Information
Roche Holding AG Grenzacherstrasse 124 Basel Basel-stadt (basle Town) 4058 |
Employees
Shareholders
| Mutual fund holders | -- |
| Individual stakeholders | -- |
| Other institutional | -- |
Top Executives
| Thomas Schinecker | Chief Executive Officer |
| Alan Hippe | Chief Financial & Information Officer |
| Levi A. Garraway | Chief Medical Officer & Head-Product Development |
| Pascale Schmidt | Chief Compliance Officer |
| Silke Hörnstein | Head-Corporate Strategy & Sustainability |
